You are here

  • Home
  • Archive
  • Volume 5, Issue 8
  • Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

Article metrics

Article menu

Download PDFPDF

XML
Gastroenterology and hepatology
Protocol
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201826263
Feb 201827193
Mar 201859559
Apr 201821193
May 201852524
Jun 201823232
Jul 201829253
Aug 201826161
Sep 201825236
Oct 201829275
Nov 201816166
Dec 201831273
Jan 201938346
Feb 201923266
Mar 201932315
Apr 201917146
May 201933256
Jun 201938359
Jul 201929274
Aug 201924218
Oct 201940364
Nov 201934327
Dec 201946447
Jan 2020373710
Feb 2020363611
Mar 202027275
May 202018183
Jun 202011118
Jul 2020131021
Aug 202019188
Sep 2020343012
Oct 2020302828
Nov 202041324
Dec 202017178
Jan 2021181810
Feb 2021302715
Mar 2021262617
Apr 2021353411
May 202134319
Jun 202117173
Jul 202120194
Aug 202127276
Sep 202132306
Oct 2021252125
Nov 2021181420
Dec 2021363613
Jan 202226211
Feb 202247396
Mar 2022716616
Apr 2022656012
May 2022696015
Jun 2022533920
Jul 202238306
Aug 202234349
Sep 2022323127
Oct 2022575514
Nov 202222205
Dec 202229299
Jan 2023413715
Feb 202334325
Mar 2023414210
Apr 202321176
May 2023302312
Jun 202328244
Jul 2023302911
Aug 2023342814
Sep 202338365
Oct 2023332615
Nov 2023273111
Dec 2023302413
Jan 2024404014
Feb 202432306
Mar 202437358
Apr 202411710
Total23692162672